Debt-to-equity of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • VERTEX PHARMACEUTICALS INC / MA Debt-to-equity for the quarter ending 30 Sep 2025 was 40%, a 18% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 40% +6% +18% 30 Sep 2025
Q2 2025 40% +8% +26% 30 Jun 2025
Q1 2025 39% +8% +28% 31 Mar 2025
Q4 2024 36% +5% +16% 31 Dec 2024
Q3 2024 34% +3% +8.1% 30 Sep 2024
Q2 2024 31% +1% +2.6% 30 Jun 2024
Q1 2024 30% 0% +0.16% 31 Mar 2024
Q4 2023 31% +1% +3.2% 31 Dec 2023
Q3 2023 31% +1% +2.7% 30 Sep 2023
Q2 2023 31% -1% -3.5% 30 Jun 2023
Q1 2023 30% -2% -6.2% 31 Mar 2023
Q4 2022 30% -3% -10% 31 Dec 2022
Q3 2022 30% -3% -9.9% 30 Sep 2022
Q2 2022 32% -4% -11% 30 Jun 2022
Q1 2022 32% -4% -11% 31 Mar 2022
Q4 2021 33% -4% -9.8% 31 Dec 2021
Q3 2021 34% -4% -9.4% 30 Sep 2021
Q2 2021 35% -3% -6.8% 30 Jun 2021
Q1 2021 36% -3% -6.8% 31 Mar 2021
Q4 2020 37% 31 Dec 2020
Q3 2020 37% 30 Sep 2020
Q2 2020 38% 30 Jun 2020
Q1 2020 39% 31 Mar 2020
Q4 2018 53% -26% -33% 31 Dec 2018
Q3 2018 63% -29% -31% 30 Sep 2018
Q2 2018 68% -38% -36% 30 Jun 2018
Q1 2018 74% -46% -38% 31 Mar 2018
Q4 2017 80% -59% -42% 31 Dec 2017
Q3 2017 92% -50% -35% 30 Sep 2017
Q2 2017 105% -40% -27% 30 Jun 2017
Q1 2017 120% -27% -18% 31 Mar 2017
Q4 2016 139% -2% -1.4% 31 Dec 2016
Q3 2016 143% +11% +8.3% 30 Sep 2016
Q2 2016 145% +24% +19% 30 Jun 2016
Q1 2016 147% +42% +40% 31 Mar 2016
Q4 2015 141% +46% +48% 31 Dec 2015
Q3 2015 132% +48% +57% 30 Sep 2015
Q2 2015 121% +42% +54% 30 Jun 2015
Q1 2015 105% +27% +34% 31 Mar 2015
Q4 2014 95% -1% -1.2% 31 Dec 2014
Q3 2014 84% -33% -28% 30 Sep 2014
Q2 2014 79% -54% -40% 30 Jun 2014
Q1 2014 78% -73% -48% 31 Mar 2014
Q4 2013 96% -44% -31% 31 Dec 2013
Q3 2013 117% -23% -16% 30 Sep 2013
Q2 2013 133% -23% -15% 30 Jun 2013
Q1 2013 151% -47% -24% 31 Mar 2013
Q4 2012 140% 31 Dec 2012
Q3 2012 140% 30 Sep 2012
Q2 2012 156% 30 Jun 2012
Q1 2012 198% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.